Helping our patient communities and advancing knowledge in our therapy areas is part of our corporate responsibility.
It is our mission to discover, develop, and deliver innovative therapies that improve patients' quality of life.
We work with government authorities to ensure patients have access to care while also funding medical research.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
Every day at CSL Behring, we work as if someone’s life depends on it, because it does.
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.
Help us deliver on our promise to save lives and protect the health of people.
Make your well-being a priority. It's important and so are you.
CSL’s Executive Vice President and Head of R&D offers advice for professional development.
It’s lights, camera, action as CSL chief Paul Perreault films employee messages in our U.S. studio.
Tapping all sources of data gives a fuller picture of patient experience.
A Q & A with Chief Communications Officer Anthony Farina.
CEO and Managing Director sits down with NPR affiliate to discuss evolving industry.
CSL Behring opens regional HQ in iconic desert city.
CSL CEO Paul Perreault highlights ongoing partnership during PSU appearance.
How can we improve access to treatment for patients?
Why improving access to care is on my mind this February – and every day.
Expanded coverage in 3 states expected to help those with rare and serious diseases.
Why CSL Behring is exploring new treatment options for this rare disease.
Healthy volunteers and rare disease patients participate in important research.
Popular search terms:
Americas
Asia Pacific
Europe
